StonvexLoading…
StonvexStonvexStonvexCore line items from AVTR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.55B | $6.78B | $6.97B | $7.51B |
Operating Income | $-246.20M | $1.08B | $696.40M | $1.13B |
Net Income | $-530.20M | $711.50M | $321.10M | $686.50M |
EPS (Diluted) | $-0.78 | $1.04 | $0.47 | $1.01 |
Total Assets | $11.79B | $12.11B | $12.97B | $13.46B |
Total Liabilities | $6.23B | $6.16B | $7.72B | $8.61B |
Cash & Equivalents | $365.40M | $261.90M | $262.90M | $372.90M |
Free Cash Flow OCF − CapEx | $495.00M | $692.00M | $723.60M | $710.20M |
Shares Outstanding | 682.00M | 680.80M | 676.60M | 674.30M |